AbilityPharma, member of CATALONIA.HEALTH, announces a strategic collaboration with AGC Pharma Chemicals, a company specialized and dedicated to the International Contract Development and Manufacturing Organization (CDMO).  

Trifermed, member of CATALONIA.HEALTH, announces the 8th edition of the Trifermed Awards for Social Impact in Healthcare. This prestigious event, founded by professor and doctor Sergi X. Trilla, will take place on September 17th in Barcelona.

The association, a recognised hub of the health and life sciences ecosystem in Catalonia, presents the new name to respond to its transversality, shaped by the great diversity of agents in the sector that make it up.

On 12 and 13 of June, ACESABIO members, of which CATALONIA.HEALTH is a member, met in Vigo at the Galicia Biodays event to discuss the impact of clusters on the development of business competitiveness.

The Center for Comparative Medicine and Bioimage of Catalonia (CMCiB), a strategic project of Germans Trias i Pujol Research Institute (IGTP), member of CATALONIA.HEALTH, celebrates five years since its launch with the event "CMCiB Symposium: 5 years Enabling Pioneering Biomedical Research".

Oxolife, member of CataloniaBio & HealthTech, presented at the 40th ESHRE annual meeting in Amsterdam the research that shows the efficacy of a non-hormonal oral drug that increases the rate of embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Asabys Partners, member of CataloniaBio & HealthTec, leads and invests in the first round of funding from its new Sabadell Asabys II fund, where Augustine Therapeutics is able to raise a total of 17 million euros. The pharmaceutical company Eli Lilly & Company and the Charcot-Marie-Tooth Research Foundation (CMT) have also participated in this round, as well as existing investors from the company. 

HIPRA, member of CataloniaBio & HealthTech, was visited by a team from HERA (Health Emergency Preparedness and Response) management department, the European Commission authority that strives to prevent, detect and respond quickly to health emergencies in the European Union. 

DevsHealth and Germans Trias i Pujol Research Institute (IGTP), both members of CataloniaBio & HealthTech, have announced a new collaboration to develop new antibiotics for multi-resistant Staphylococcus aureus infections.

Nanomol Technologies, member of CataloniaBio & Healthtech, obtains the authorization of the Spanish Agency for Medicines and Health Products (AEMPS) as a pharmaceutical laboratory for the control of physicochemical quality of medicines for human, veterinary use and in research. 

Mitelos, member of CataloniaBio & HealthTech, has announced its expansion into six new markets: Perú, the United Kingdom, Ireland, New Zealand, Finland, and Iceland. This strategic move marks a significant step forward in the company’s mission to make its products available to doctors, pharmacists and patients. 

As part of the roundtables organized by CataloniaBio & HealthTech within the Girona Talent programme, a Hospital Connection has been launched to identify the unsolved clinical needs of ICS Girona and the Institut d'Assistència Sanitària. The format is an initiative of the internal innovation committee and has already "stopped by" at the Hospital Sant Joan de Déu in Barcelona this year. This new event was held on Wednesday, June 12th, at La Farinera Teixidor with clinical professionals from the main healthcare centres in Girona. 

The life sciences and health ecosystem in Catalonia has an important cluster in the Girona region, with growing representation among the members of CataloniaBio & HealthTech. To highlight this fact and give it visibility, CataloniaBio & HealthTech has collaborated with the drivers of Girona Talent to organise a conference to discuss, with experts and members of the entire value chain, the opportunities and challenges of the health ecosystem in Girona, as part of the events of the week. In this context, a Hospital Connection has also been launched to explore the unmet clinical needs of the ICS Girona and the Institut d'Assistència Sanitària. The sessions were held on Wednesday, 12 June, at La Farinera Teixidor. 

This 2024, two CEO Council meetings have been held and the date for the next one is already set for July 4th, with Vanessa Servera (Institut Català de Finances) as the special guest. What makes these sessions special? They are small group talks held in practe, where CEOs and members of startup and CataloniaBio & HealthTech company boards can participate and engage directly with the guest speakers, a high-level expert, whether business leaders or political decision-makers, with whom they can share experiences and strategic perspectives for their companies and the sector. 

The European Hematology Association has awarded one of its renowned "Bilateral Collaborative Grants" to the collaborative project of Dr. Biola M. Javierre, from the Josep Carreras Institute, member of CataloniaBio & HealthTech, and Dr. Björn Chapuy, from Charité Universitätsmedizin Berlin (Germany).

The Hospital Sant Joan de Déu Barcelona and the Amancio Ortega Foundation have signed a collaboration agreement to promote research into rare diseases. The signing took place at the hospital itself, in the presence of the president of the foundation, Flora Pérez Marcote, and the managing director of the Hospital, Manel del Castillo.

Mediktor, member of CataloniaBio & Healthtech, announced the acquisition of Sensely, digital healthcare provider that pioneered an empathy-driven conversation platform to support hospital systems and insurance services with world-class member engagement. This consolidation of two world-leading artificial intelligence-driven solutions providers marks a major medical technology milestone, extending Mediktor’s global presence to more than 35 countries and expanding its footprint in the United States. 

Vitalera, formerly HumanITcare, member of CataloniaBio & HealthTech, is taking a qualitative leap by adding new allies that will contribute to scaling and projecting its digital solutions, with the United States as its focus. 

Onalabs, member of CataloniaBio & HealthTech, announced the pre-commercial launch of the ONASPORT device, in collaboration with the Barça Innovation Hub (BIHUB), responsible for fostering and promoting innovation in the field of sports.  

Vytrus Biotech, member of CataloniaBio & HealthTech, has closed a 2.3 million euros capital round, through a capital increase and the sale of shares, in which it has increased and renewed part of its shareholder base.